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Mitochondria are highly dynamic organelles that in response to the cell’s bio-energetic
state continuously undergo structural remodeling fission and fusion processes. This
mitochondrial dynamic activity has been implicated in cell cycle, autophagy, and
age-related diseases. Adult tissue-derived mesenchymal stromal/stem cells present
a therapeutic potential. However, to obtain an adequate mesenchymal stromal/stem
cell number for clinical use, extensive in vitro expansion is required. Unfortunately,
these cells undergo replicative senescence rapidly by mechanisms that are not well
understood. Senescence has been associated with metabolic changes in the oxidative
state of the cell, a process that has been also linked to mitochondrial fission and fusion
events, suggesting an association between mitochondrial dynamics and senescence.
In the present work, we studied the mitochondrial structural remodeling process of
mesenchymal stromal/stem cells isolated from adipose tissue in vitro to determine if
mitochondrial phenotypic changes were associated with mesenchymal stromal/stem
cell senescence. For this purpose, mitochondrial dynamics and oxidative state of
stromal/stem cell were compared between young and old cells. With increased cell
passage, we observed a significant change in cell morphology that was associated
with an increase in β-galactosidase activity. In addition, old cells (population doubling
seven) also showed increased mitochondrial mass, augmented superoxide production,
and decreased mitochondrial membrane potential. These changes in morphology were
related to slightly levels increases in mitochondrial fusion proteins, Mitofusion 1 (MFN1),
and Dynamin-related GTPase (OPA1). Collectively, our results showed that adipose
tissue-derived MSCs at population doubling seven developed a senescent phenotype
that was characterized by metabolic cell changes that can lead to mitochondrial fusion.
Keywords: adipose derived mesenchymal stromal cells, mitochondria, reactive oxygen species, senescence,
fission and fusion
INTRODUCTION
Mesenchymal stromal/stem cells (MSC) were described by Friedenstein almost 50 years ago as
plastic adherent fibroblast-like cells (Friedenstein et al., 1968, 1970, 1976). Caplan in 1991 referred
to MSC as cells with regenerative potential in tissues of mesenchymal origin such as bone, cartilage,
muscle, ligament, tendon, adipose, and stroma, thus he coined the term “mesenchymal stem
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cell” (Caplan, 1991). Multilineage differentiation potential was
demonstrated by Pittenger et al. identifying this population as
adult stem cells with stable phenotype (Pittenger et al., 1999).
MSCs are highly metabolically, with a vast array of molecules
secreted into the extracellular matrix (ECM), in addition to
cytokines (Keating, 2012). Therefore, for the past 15 years
MSCs have become very popular because of their therapeutic
potential in tissue regeneration and cancer treatment (Schipani
and Kronenberg, 2009; Dong and Caplan, 2012; Droujinine et al.,
2013). The number of clinical trials on MSCs has been rising
since 2004, including phase I–IV clinical studies for myocardial
infarction, graft versus host disease, diabetes, spinal cord injury,
and others. However, numerous scientific issues remain to be
resolved before the establishment of clinical standards and
government regulations (Wei et al., 2013).
Most therapeutic protocols require ex vivo cell expansion,
guaranteeing reproducible, cost-effective, and good
manufacturing practices. Although state of the art protocols
describing systems such as microcarrier-based stirred cultured
system have been reported (Carmelo et al., 2014), less is
known about MSC expansion and senescence. To describe
the phenotype acquired by MSC population after sequential
cell passaging, characterized by low proliferation, and loss of
clonogenic and differentiation potential, some researchers
have used proteomic analysis to understand molecular
mechanisms underlying replicative senescence (Madeira
et al., 2012). Others have described epigenetic modifications
during in vitro culture, where cells acquire DNA methylation
changes at specific genomic sites (Schellenberg et al., 2014).
Furthermore, telomere length and telomerase activity has
been a hallmark during MSC expansion protocols (Parsch
et al., 2004). Indeed it can be used as a method to track
cellular changes upon long term culture (Wagner et al.,
2010).
In addition to telomere shortening and telomerase activity
inducing senescence, free radical, and mitochondrial theory
are notable theories on aging (Andreyev et al., 2005; Romano
et al., 2010). Decreased mitochondrial function is critical in
the aging process and has been associated with age-related
disorders (Seo et al., 2010). Mitochondria have been described
as the major producers of free radical and concurrently the
principal target of free radical action (Harman, 1972). The
mitochondrial free radical theory of aging proposes reactive
oxygen species (ROS), produced as by-products during normal
metabolism results in oxidative damage (Sanz and Stefanatos,
2008). In response to a cell’s bio-energetic state mitochondria are
constantly remodeled. This process is known as mitochondrial
dynamics, and is an integral part of many cellular responses.
These dynamics are characterized by fission and fusion events
that allow mitochondrial changes in orientation, number, and/or
size within the cell. These tightly regulated processes allow
constant remodeling of mitochondria (Hoppins et al., 2007).
Conditions such as hypoxia, stress, and aging have been
reported to impact mitochondrial dynamics leading to cellular
dysfunction. Recently, mitochondrial fusion has been shown to
induce senescent-like phenotypes in human cell cultures (Lee
et al., 2007).
Mitochondrial fusion has been proposed to occur through
two independent mechanisms in mammalian cells by which
the inner and outer membrane fuse separately (Griffin et al.,
2006). Fusion is believed to impart functional protection for
the mitochondria by allowing them to exchange contents that
might alleviate damaged constituents and promote repair (Seo
et al., 2010). There are currently three established fusion proteins,
Mitofusion proteins 1/2 (Mfn1/2) and optic atrophy protein
1 (Opa1). Over expression of Mfn 1/2 has been shown to
inhibit apoptosis and promote cell survival (Sugioka et al., 2004).
Furthermore, Fzo1, a protein involved in mitochondrial fusion,
inhibits apoptosis (Sugioka et al., 2004). Mitochondrial fission
participates in mitosis. In addition, it is thought to contribute to
and even regulate apoptosis, as well as participate in the removal
of dysfunctional mitochondria via mitophagy (Seo et al., 2010).
In humans there are currently two established fission proteins,
dynamin-related protein 1 (Drp1) and fission 1 protein (Fis1).
Reports in the literature suggest mitochondrial dynamics
might play a role in senescence and aging, and could induce or
alleviate these phenotypes (Ziegler et al., 2015). We proposed
to study the mitochondrial structural remodeling process during
in vitro culture. We set out to characterize possible fission and
fusion events to establish the relationship between mitochondrial
dynamics and replicative senescence.
MATERIALS AND METHODS
MSC Isolation and Population Doubling
Determination
Mesenchymal stromal/stem cells were isolated from processed
lipoaspirate. Adipose tissue was collected after informed
signed consent from females (n = 3) undergoing cosmetic
surgery with the approval of the Bioethics Committee at
the Pontificia Universidad Javeriana. Processed lipoaspirate
MSCs were isolated and characterized as previously described
(Gutiérrez et al., 2013). Cells were passaged after reaching 80%
confluency. Cell Media was changed twice a week, and MSCs
were harvested and passaged according to the standardized
protocol and re-seeded at a density of 104 cells/cm2. Population
doubling (PD) was established as follows:
PD = log(N/Ni)× 3.32 (1)
N= number of viable cells, Ni= initial seeded number of cells.
MSCs Characterization
Cells at passage one were trypsinized and 96 × 103 cells were
seeded in six well plates and incubated with complete media for
24 h. Adipogenesis and osteogenesis was evaluated with media
supplemented with inducers according to Gutiérrez et al. (2013).
Senescent Phenotype
Mesenchymal stromal/stem cells were serially passaged until they
reached a state of senescence defined as the inability to achieve
80% confluency after feedings over a 4 week period, verified by
the senescence-associated β-galactosidase assay.
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Senescence-Associated β-Galactosidase
Assay
After reaching 80% confluency cells were detached and re-
seeded at a 3 × 104/6 well plate and incubated at 37◦C,
5% CO2 for 24 h. Histochemical detection of β-galactosidase
expression at pH 6.0 was only present in senescent cells and
not pre-senescent cells, evidenced by x-gal conversion into a
blue stain. Beta-galactosidase activity was evaluated following
manufacturer’s instructions (Senescence, β-galactosidase kit,
Millipore, Massachusetts, USA). Last, SA β-gal cell stain count
was performed under light microscopy and percentage of positive
cells was calculated.
Mitochondrial Dynamics Characterization
Mitochondrial Mass
MSCs were stained with MitoTracker Green FM (Invitrogen,
Carlsbad CA, USA) to quantify functional mitochondrial mass.
Briefly, 48 h prior to staining 1 × 104 cells were seeded
using 35 mm glass bottom culture dishes, containing 14mm
microwell (MatTek, MA, USA). Cells were incubated for 30
min with DMEM supplemented with 80 nM MitoTracker Green
FM, followed by 5µM CellTracker Red CMTPX solutions to
stain the cytoplasm (Invitrogen), and Hoechst (Invitrogen) to
define cell nucleus. Cells were observed in vivo, and 2D and
3D images were collected by confocal microscopy using an
Olympus FV1000 with an excitation/emission range of 400/545
for MitoTracker Green FM and 577/602 nm for CellTracker
Red CMTPX. Z-stack parameters were as follows: ∼15 z-axis
slices at ∼0.50µm intervals with a final Z-stack thickness of
∼7.5µm. Mitochondrial mass was determined by data obtained
from confocal microscopy in voxel units.
Mitochondrial Membrane Potential
Briefly, cells were collected as described for β-galactosidase assay
and cultured for 48 h. We performed the established protocol
for Mitoprobe
TM
JC-1 Assay Kit for Flow Cytometry (Molecular
Probes, Invitrogen USA). We added 200 µM JC-1 and incubated
for 30min at 37◦C. To determine mitochondrial membrane
potential flow cytometry analysis was performed in a Guava
easyCyte Flow cytometer (EMD Millipore, Billerica MA USA)
at 488 nm excitation and 530 and 580 nm emission range with
bandpass emission filters. Non-cellular debris and dead cells were
gated out based on the light-scattering properties in the Side-
and Forward- scatter parameters, and approximately 10 × 103
events from live cells were collected for each analysis. Exposure
to 50µM carbonyl-cyanide 3-chlorophenylhydrazone (CCCP)
(Sigma Aldrich, St Louis MO USA) for 10 min was used as a
control to set the threshold of fluorescence intensity for cells with
intact mitochondrial membrane potentials. Results are presented
as the percent of all cells with Mitoprobe fluorescence greater
than the threshold set by CCCP.
Mitochondrial Anion Superoxide Production
After reaching 80% confluency cells were detached and re-seeded
at a 3 × 104/6 well plate and incubated at 37◦C, 5% CO2 for
48 h. MitoSOX Red mitochondrial superoxide indicator for live-
cell imaging (Molecular Probes, Invitrogen) assay was performed
as an indicator of mitochondrial superoxide production. As a
positive control 50µM rotenone (Sigma) was used for 1 h. As a
negative control we used 1X PBS without marker. Analysis was
performed in Guava cytometer at 510/580 excitation/emission
ranges. Results are presented as arbitrary units of fluorescence.
Fusion and Fission Protein Identification
Cells were harvested as described above in the cell culture
method and lysed with lysis buffer (50 mM Tris-HCl, pH 7.5,
0.1M NaCl, 1 mM EDTA, 10mM MgCl2, 1% Triton X-100, and
protease inhibitor cocktail). Sample protein concentration was
determined by Bradford assay (Pierce). Equivalent amounts of
proteins (25µg) were separated by SDS-PAGE, transferred to
nitrocellulose membranes, and immunoblotted. The following
antibodies: MFN1 (Abcam,MAUSA), OPA1 (Abcam,MAUSA),
DRP (Abcam, MA USA), and FIS1 (Abcam, MA USA), were
used to determine if fusion or fission processes at the selected
time-points were taking place. Immunoblots were visualized by
the enhanced chemiluminescence system (JPI Healthcare Co,
Plainview NY USA), β-actin (Abcam, MA USA) was used as
the control and ProSieve QuadColor Protein Marker, 4.6–300
kDa as a reference for protein identification (Lonza, Allendale
NJ USA). Protein quantification was performed in ImageJ
(NIH) by normalizing mitochondrial dynamic protein to β-actin.
Difference is reported as arbitrary units.
RESULTS
MSC Characterization and Senescent
Phenotype
In order to characterize the effects of consecutive cell passaging
on human MSCs proliferative capacity and mitochondrial
metabolism, samples from three independently isolated
healthy donors were cultured for seven consecutive passages
(P1–P7) using DMEM supplemented with 10% FBS. Initial
characterization at two population doublings (PD2) of these
adipose derived-mesenchymal stromal/stem cells showed that
these cells had high capacity of adherence to plastic, fibroblast-
like morphology, and specific cell surface antigen expression
of CD73, CD90, and CD105, and lack of CD34 expression
(Figures 1A,B). Furthermore, adipose derived-mesenchymal
stromal/stem were able to differentiate into adipogenic and
osteogenic linages (Figures 1C,D) (Dominici et al., 2006;
Gutiérrez et al., 2013).
MSCs isolated from adipose tissue reached population
doublings seven (PD7) after 130 days in culture and their
growth was characterized by having a logarithmic proliferation
rate during the first 40 days followed by a plateau phase
in which MSCs were unable to achieve a 80% confluency
over a 4 week period (Figure 2A). Upon light microscopy
examination, significant changes in morphology were observed
during consecutive passaging expansion. Comparison of MSCs
morphology between PD 2 and 7 showed an increase in cell
size, as well as a visible augmentation in cell granularity for
PD7 cells. Namely, over 60% of MSCs at PD7 acquired a
flattened and widened phenotype that was accompanied with a
severe decrease in cell proliferation, suggesting that cells at PD7
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FIGURE 1 | MSCs characterization. (A) Representative sample illustrating immunophenotypic profile. Antibodies against CD34, CD73, CD90, and CD105 (thick
gray lines) with isotype control (thin gray lines). (B) Percentage expression corresponding to the average profile of all cell types (n = 3). (C) Representative sample of
MSCs induced into adipogenic lineage differentiation. Neutral fat lipid droplets were detected by Oil red O stain (D) Representative sample of MSCs induced into
osteogenic differentiation. Extracellular calcium deposits were determined by Alizarin Red stain. Scale bar 100µm.
were in a senescent state (Figure 2B). To further corroborate a
senescent phenotype at PD7, we used the senescence-associated
β-galactosidase stained assay (SA β-gal) with optimum activity
at pH 6.0. In MSCs cultured up to PD7 we observed a marked
increase in SA β-gal activity compared with PD2 (Figures 2C,D).
Hence, we evidenced thatMSCs cultured up to PD7 after 130 days
in culture exhibited a senescent phenotype.
Mitochondrial Dynamics Characterization
It is well established that MSCs can reach a senescent phenotype
during in vitro proliferation and lose their differentiation
potential, with alteration of their metabolic profile (Wagner
et al., 2010; Geissler et al., 2015). Senescence has been associated
with metabolic changes in the oxidative state of the cell, a
process that has been linked to mitochondrial fusion and fission
events (Mitra, 2013; Geissler et al., 2015). During the process of
fusion and fission mitochondria can adjust their size, shape, and
organization inside the cell (Westermann, 2010; Mitra, 2013).
Significance of mitochondrial configuration changes has only
recently begun to be understood, and might play a role in
the regulation of senescence processes in MSCs. Therefore, we
characterized mitochondrial changes for MSCs cultured at lower
passage and higher passage number (PD2 vs. PD7) in adipose
derived MSCs.
Morphological differences between young and senescent cells,
as was described for bright-field microscopy, were also observed
by using the CellTracker fluorescent dye (Figure 3). Digital
rendering of Z-stack depicting the cell cytoplasm through
CellTracker red evidenced young cell fibroblast morphology
(Figure 3A) in contrast to senescent cells (Figure 3D), where
an increased in cytoplasmic cell surface was observed. Likewise,
morphological analysis of mitochondria at PD2 cells -using
the mitochondrial marker MitoTracker green showed small
tubular mitochondria forming a slightly interconnected network
(Figures 3B,C). In contrast, PD7 cells had large tubular
mitochondria forming an intricate network that was uniformly
distributed in the cytoplasm (Figures 3E,F).
To further corroborate if mitochondrial morphological
changes were associated with mitochondrial volume, we
quantified mitochondrial mass. Our results showed that PD7
MSCs had a larger mass (1286± 160) compared with PD2 (663.5
± 104). These results suggest that increased adipose derived
MSCs cell expansion lead to a senescent state characterized by
an augmented mitochondrial network and mass. Mitochondrial
dynamics fusion and fission are critical for organelle inheritance
and maintenance of mitochondrial functions (Westermann,
2010). It has been described that increased mitochondrial
mass could be associated with fusion processes. Therefore, we
evaluated if changes in mitochondrial mass observed were due
to changes in the levels of proteins involved in fusion and fission
processes. Results showed a slight tendency for an increased level
in fusion proteins GTPase, Mitofusion 1 (MFN1) and Dynamin-
related GTPase OPA1 (Figure 4A), and in fission protein Fission
1 (FIS1) (Figure 4B). In contrast, fission protein DRP1 did
not have important protein level difference between young and
old populations. Collectively, our results suggest a tendency
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FIGURE 2 | MSCs senescent associated phenotype. (A) Cumulative Population doubling for adipose derived MSCs. Adipose tissue derived MSCs were cultured
for a total of 131 days. Cumulative PD were calculated at the end of every passage in relation to cell number of the first passage (n = 3). (B) Percentage senescent
cells determined by cell count/field. Over 60% of MSCs at PD7 acquired a flattened and widened phenotype. (C) Representative brightfield images of young and
senescent MSCs. Young cells are spindle shaped and slender in contrast to senescent cells with a widened and flat morphology. Cells presenting blue staining
indicate the presence of β-galactosidase activity in senescent cells. Scale bar 100µm. (D) Quantification of β-galactosidase positive cells for young (PD2) and
senescent cells (PD7).
for fusion events in senescent cells, favoring the formation of
mitochondrial networks. In response to mitochondrial stress
fusion possibly protects the cell by maintaining a functional
population of mitochondrial within the cell.
Mitochondrial Metabolic Characterization
It has been shown that mitochondrial fusion is a mechanism
used by the cell to dilute out mitochondrial dysfunction, respond
to high energy demands, and maintain proper cell function.
Since we observed mitochondrial mass changes in senescent
MSCs associated with increased fusion, we then proceeded to
evaluate mitochondria functionality by assaying mitochondrial
membrane potential (1ψm) and ROS production (Zorov et al.,
2014).
Mitochondrial functionality by membrane potential was
quantified by using the FACS JC-1 fluorescence dye. This cationic
carbocyanine dye accumulates in the mitochondria in a low
monomeric concentration yielding a green fluorescence when
the membrane potential is low. On the other hand, it aggregates
at high concentrations with a red fluorescence emission at
high membrane potentials. Our results showed a 47% reduction
in 1ψm for cells at PD7 in comparison with cells at PD2
(Figure 5A). These results suggest that senescent MSCs have a
diminished mitochondrial energetic capacity, which may lead
to a lower activity in mitochondrial respiration and less ATP
synthesis.
Subsequently, we characterized ROS production in young
and senescent MSCs to evaluate the activity of mitochondrial
respiration in these cells. Reactive oxygen species (ROS) are
electron transporter chain (ETC) by-products of the cell’s
oxidative metabolism. A normal balance in ROS production
and inactivation is mediated by different enzymatic systems
and exogenous molecules capable of ROS detoxification to
prevent oxidative stress damage (Sanz and Stefanatos, 2008). If
mitochondria homeostasis is not sustained, higher ROS levels
are produced. This in turn results in longer mitochondrial
permeability transition pore (mPTP) openings releasing a ROS
burst leading to mitochondria destruction. If these events are
propagated from mitochondrion to mitochondrion, they might
result in cell apoptosis (Zorov et al., 2014). Furthermore, reports
have shown prolonged elongated mitochondria result in higher
ROS production and lower mitochondrial respiration activity,
resulting in cellular senescence (Yoon et al., 2007; Wagner et al.,
2008).
Mitochondria superoxide production was evaluated by FACS
analysis, where the reagent permeated live cells, selectively
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FIGURE 3 | Mitochondrial characterization. MSC cell morphology and mitochondrial mass evaluation by confocal microscopy. (A) MSC at PD2 cytoplasm
revealed by CellTracker red. (B) Mitochondrial stain with Mito Tracker green for MSCs at PD2. (C) Merge for (A) and (C) with nucleus stained with Hoechst (blue). (D)
Larger cytoplasm in MSC at PD7 revealed by CellTracker red. (E) Mitochondrial stain with Mito Tracker green for MSCs at PD7. (F) Merge for (A) and (C) with nucleus
stained with Hoechst (blue). Scale bar 50µm for all images.
targeting mitochondria, and rapidly oxidizing to produce
a highly fluorescent product. Our data determined anion
superoxide production was 2.37 fold higher for senescent
MSCs cultured up to PD7 compared with young MSCs
(Figure 5B). Collectively, these results show that old MSCs have
a decreased mitochondrial membrane potential, and increased
ROS production, while young MSC have a conserved membrane
mitochondrial potential and decreased ROS production. These
results suggest that senescentMSC could have deficiencies in ATP
production and an increase in oxidative stress. Old MSCs can
compensate these mitochondrial changes with an augmentation
in mass and interconnected mitochondrial network favored
by the fusion process. Together, our results suggest possible
mitochondrial functional changes that could be associated with
senescence.
DISCUSSION
Mesenchymal stromal/stem cells have a great potential for
therapeutic use; and human adipose tissue is an ideal autologous
source of MSCs for diverse regenerative medicine and tissue
engineering strategies (Caplan and Correa, 2011; Jin et al., 2013;
Choudhery et al., 2014). Mesenchymal stem/stromal cells have
been widely described in the literature for their therapeutic
potential as anti-inflammatory, immuno-modulatory, and
trophic support (Caplan and Correa, 2011; Choudhery et al.,
2014). Most therapeutic protocols require ex vivo cell expansion
to attain desired numbers, generally described as 1 × 106/kg
weight (Wagner et al., 2010). This requirement induces deficiency
in cell proliferation capacity, loss of clonogenic potential, and
impairment in differentiation potential (Madeira et al., 2012; Jin
et al., 2013). Moreover, cells acquire DNAmethylation changes at
specific genomic sites brought about by epigenetic modifications
during in vitro culture (Bentivegna et al., 2016). Therefore,
MSCs proliferation and senescence are important issues to be
considered for clinical safety and efficacy.
Our results demonstrate that for adipose tissue-derived MSCs
a senescent phenotype was observed for cells cultured up to
seven population doublings. This was evidenced by changes
in cell morphology, decreased cell proliferation, and positive
SA β-gal stain as previously described (Wagner et al., 2008).
In addition to this characterization, we defined mitochondrial
functional changes possibly related to replicative senescence
to shed light on potential mitochondrial associated aging
process. Senescent MSCs had an increased mitochondrial
mass and strongly interconnected network that distributed
uniformly in the cytoplasm, suggesting potentiation of fusion
processes. Therefore, characteristic mitochondrial tubular shape
was observed. In addition to slightly increased fusion associated
proteins, MFN-1 and OPA1.
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FIGURE 4 | Mitochondrial dynamics protein evaluation. (A) Mitochondrial
fusion proteins MFN1 and OPA1. (B) Mitochondrial fission proteins DRP1 and
FIS1. Bar graphs depict protein expression as an arbitrary unit when protein of
interest was normalized to β-actin. MFN1, Mitofusion1; OPA1, Optic atrophy 1;
DRP1, Dynamin-1-like protein; FIS1, Mitochondrial fission 1.
Mitochondrial dynamics are defined by the capacity of this
organelle to continuously fuse or divide (Westermann, 2010).
The balance between these two processes is responsible for
mitochondria shape, distribution, inheritance, and functionality.
If this delicate balance is lost, mitochondrial and cellular
functions are affected as well (Detmer and Chan, 2007;
Terman et al., 2010). Mitochondria can continually exchange
contents through membrane fusion. This process controls
organelle shape and is critically important for maintaining
mitochondrial network function (Suen et al., 2008; Correia-
Melo et al., 2016). We observed changes suggesting fusion
events in senescent MSCs, based on a slightly higher MFN1
and OPA1protein levels. The most relevant proteins involved
in mitochondrial fusion process are three GTPase dynamin-
like proteins: Mitofusion 1 (MFN1) and 2 (MFN2), located in
the outer mitochondrial membrane, and optic atrophy protein
1 (OPA1), in the inner membrane (Westermann, 2010). It
is conceivable that under normal conditions outer membrane
FIGURE 5 | Mitochondrial membrane potential and Reactive oxygen
species production in young and senescent MSCs. (A) FACS analysis to
determine membrane potential changes by means of JC-1, a lipophilic cationic
dye selectively entering into mitochondria. JC-1 accumulation in mitochondria,
due to concentration-dependent formation of red fluorescent JC-1 aggregates
was higher for MSCs cultured up to PD2 compared with PD7 MSCs. Results
are presented as JC-1 aggregates/JC-1 monomer (B). Reactive oxygen
species production in young and senescent MSCs was compared by Mitosox
Red fluorescent intensity production quantified by flow cytometry and
expressed as arbitrary units fluorescence ROS (AUF). As a positive control
rotenone at 50 µM was used.
fusion is coordinated with inner membrane fusion. Even though
we did not evaluate MFN2, our data evidenced slightly increased
outer and inner mitochondrial membrane protein expression
in aged MSCs. Under these conditions senescent MSCs would
possibly use fusion processes to connect neighboring depolarized
mitochondria and unite their contents to maintain membrane
potential (Ikeda et al., 2015). Mitochondrial fusion has been
reported to be beneficial for cardiomyocytes under stress
conditions, since it consolidates the mitochondria’s ability
to supply energy (Ikeda et al., 2015). It is plausible this
increased mitochondrial networking could be serving as a
protective mechanism. It has been suggested mitochondrial
fusion may protect neurons form excessive mitochondrial stress
by maintaining a functional population (Ikeda et al., 2015).
In contrast, mitochondrial fission can segregate damaged
mitochondria from intact ones, and the injured part of the
mitochondria is phagocytized by mitophagy (Ikeda et al., 2015).
Dynamin-related protein 1 (DRP1) is a master regulator of
mitochondrial division (Westermann, 2010). Recruitment of
DRP1 from the cytosol and assembly in the mitochondria
depends partly on mitochondrial fission protein (FIS1). Both
proteins are located on the external mitochondrial membrane.
Our findings demonstrated younger cells expressed insignificant
increased levels of DRP1, while senescent MSCs had a negligible
increment in FIS1 expression.
Studies from in mouse embryonic fibroblasts (MEF)
evidenced maintenance of mitochondrial morphological
dynamics during cell stress can occur either by blocking fission
(via dominant negative mutant-Drp1) or enhancing fusion (via
Mfn1, Mfn2), suppressing mitochondrial injury and subsequent
apoptosis. Furthermore, it has been reported Mfn1 and Mfn2
can maintain mitochondrial morphology during cell stress, and
prevent mitochondrial outer membrane permeabilization and
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FIGURE 6 | Mitochondrial dynamic Model proposal for MSCs. Young MSCs can readily undergo proliferation. Mitotic cells have slightly higher DRP1 expression,
possibly regulating mitochondrial fission. Senescent MSCs display mitochondrial fusion. In addition they have larger mitochondrial volume; express proteins
associated with fusion events most likely as an adaptation mechanism to energetic changes, such as increased ROS production, and decreased 1ψm possibly to
prevent apoptosis.
apoptosis (Brooks et al., 2011). In senescent MSCs, a hypothesis
proposing fusion process enhancement mediated by Mfn1,
could suppress apoptosis. Future studies associating intrinsic
apoptosis signaling pathways would elucidate these mechanisms
in senescent MSCs.
Among the principal pathways toward senescence reported
in the literature associated with senescence are telomere
shortening and ROS species production by mitochondria. To
date to the best of our knowledge no study has addressed
mitochondrial functional changes associated changes with
replicative senescence in adipose derived MSCs. Mitochondria
are involved in multiple anabolic and catabolic reactions, such as
citric acid cycle and β-oxidation, in addition to their prominent
role in metabolic energy production. Furthermore, they
participate in developmental processes of aging (Westermann,
2010).
Our data show that old MSCs have a decreased mitochondrial
membrane potential, and increased ROS production, while
youngMSC have a conservedmembranemitochondrial potential
and decreased ROS production. These results suggest that
senescent MSCs could have deficiencies in ATP production and
an increase in oxidative stress.
The mitochondrial crisis can be described as a decrease in
electron chain transport, diminished membrane potential1ψm,
decreased oxidation, increased ROS production, and diminish
mitochondrial function. Our data suggest a mitochondrial
impairment could have occurred in senescent MSCs. Other
authors have described for human fibroblast under oxidative
stress during replicative senescence, ROS associated with
increased mitochondrial mass (Lee et al., 2002). For the
fibroblast study increase in mitochondrial mass was attributed to
sublethal increased levels of oxidative stress. It is likely increased
ROS production resulted in augmented mitochondrial mass,
contributing to MSCs senescent phenotype. Furthermore, since
Harman in 1956 proposed the free-radical theory of aging, where
cumulative damage to molecules by ROS leads to irreversible
cell damage and functional decline (Harman, 1956), this theory
has also been extended including mutations and deletions in
mitochondrial DNA. These accumulated age related mutations
and deletions lead to impaired function of the respiratory chain
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and increase ROS production; generating a vicious cycle (Seo
et al., 2010).
In conclusion, our study describes mitochondrial functional
changes associated with adipose derived MSCs senescent
phenotype after PD7. Increased MFN1 expression in PD7 MSCs,
favoring fusion, could be suggestive of a protective mechanism
against cells undergoing apoptotic events. Furthermore,
metabolically MFN1 could potentiate membrane potential
allowing the “senescent phenotype” MSC to adapt to stress. Our
data suggest that the aging process could be associated with
impaired mitochondrial function and energy metabolism in
MSCs. However, further studies are required to define metabolic
changes that accompany the mitochondrial crisis here described.
Results derived from this study should be taken into account
when considering MSC expansion for therapeutic use; as our
data revealed mitochondrial functional changes associated with
replicative senescence in cells with higher PDs.
Our findings propose fusion and fission processes
could be regulated under stress conditions for PD7 MSCs
(Figure 6). Mitochondrial dynamics might be aiding in
regulating mitochondrial ATP cellular levels and minimizing
damaged mitochondrial DNA (mtDNA) accumulation during
aging. We show fusion is important in senescent MSCs, perhaps
to protect cells against oxidative stress and energy failure. During
aging mitochondrial capability to generate ATP declines and
mutations in mitochondrial and nuclear DNA accumulate
(Stewart and Chinnery, 2015). However, to date the relationship
between mitochondrial dynamics, and energy metabolism in
young and senescent MSCs is still poorly understood and should
be taken into account when considering MSCs for therapeutic
applications.
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